Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors › Research Explorer

Novosibirsk State University's Research Portal

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors

Research output: Contribution to journal › Article › peer-review

DOI

https://doi.org/10.1021/acsmedchemlett.1c00299
Final published version

Dmitriy Shcherbakov
Dmitriy Baev
Mikhail Kalinin
Alexander Dalinger
Varvara Chirkova
Svetlana Belenkaya
Aleksei Khvostov
Dmitry Krut'Ko
Aleksei Medved'Ko
Ekaterina Volosnikova
Elena Sharlaeva
Daniil Shanshin
Tatyana Tolstikova
Olga Yarovaya
Rinat Maksyutov
Nariman Salakhutdinov
Sergey Vatsadze

Original language	English
Pages (from-to)	140-147
Number of pages	8
Journal	ACS Medicinal Chemistry Letters
Volume	13
Issue number	1
Early online date	29 Sept 2021
DOIs	https://doi.org/10.1021/acsmedchemlett.1c00299
Publication status	Published - 13 Jan 2022

Research areas

3,7-diazabicyclo[3.3.1]nonane, bispidinone, inhibition, molecular docking, SARS-CoV-2 main viral protease

OECD FOS+WOS

1.06.CQ BIOCHEMISTRY & MOLECULAR BIOLOGY
1.04.EE CHEMISTRY, ORGANIC
3.01.TU PHARMACOLOGY & PHARMACY

ID: 34447322